Scharen-Guivel Hilda Frederique sold $117K of IRMD
Scharen-Guivel Hilda Frederique sold 1,234 shares of IRADIMED CORP (IRMD) at $95.00 ($0.12M total) on 2026-06-04.
How this was made
The 30-second read
Why it matters
This provides incremental sentiment information but lacks fundamental drivers (earnings, guidance, deals, litigation, or regulatory actions).
Market read
Traders may monitor whether additional insider sales/buys follow, but the disclosure alone is unlikely to materially reprice the stock.
What to watch
Director sales can be routine or tax-related; the article provides no reason for the sale or whether other insiders increased/decreased positions around the same time.
Background
The article is an SEC EDGAR Form 4 insider transaction disclosure for IRMD, reporting a director’s open-market sale.
Ticker impact
SEC Form 4 shows IRMD director Hilda Frederique Scharen-Guivel sold 1,234 shares at $95 on 2026-06-04.
Likely limited immediate price impact; watch for follow-on insider activity or changes in trading plans.
The filing is a single director sale with no stated 10b5-1 plan and no accompanying fundamental catalyst in the article.
Market effects
No sector-wide implications; this is company-specific insider trading disclosure.
None indicated.
None indicated.
Counterpoint
Without a 10b5-1 plan, the sale could reflect liquidity needs rather than bearish expectations; one transaction is not a trend.
Key entities
- issuerIRMD
IradiMed Corp; subject of the Form 4 insider sale disclosure.
- insiderScharen-Guivel Hilda Frederique
Director who sold 1,234 shares on 2026-06-04.
